Our partners
HOW WE COLLABORATE
Working together with academics and pharma, we drive innovation and accelerate programmes through to clinical readiness.
We understand that every drug discovery idea is unique. That’s why we work with you to address your specific challenges and goals, ensuring you receive the support you need at every stage of your journey.
What we bring to our partnerships:
- A collaborative mindset
- Progression at pace
- Focus on the final product
- A patient-centric approach
Our Platform
How we work to enable early science to thrive
Working with academics and pharma, we empower groundbreaking ideas, providing our programmes the required resources, the meaningful mentorship and the strategic support necessary to transform promising early-stage science into impactful biotech assets.
Early academic drug discovery projects
Programme entry
Securing groundbreaking early science discoveries from world-class scientists and key opinion leaders across the globe:
- Highest quality scientific hypotheses
- Innovative targets with strong linkage to mechanism of disease
- Novel therapeutic approaches
- Compelling areas of unmet need
Chemical matter
identified
Propulsion through the Slingshot platform
Programme acceleration
Moving at pace to accelerate initial ideas into robust candidate medicines:
- Proactive programme planning and risk management
- Multidisciplinary approach to programme progression; built around the founding science
- Structured milestones and programme governance
- A wealth of scientific and drug development advice, available from the outset
Development candidate identified
Individual programmes prepared for clinic
Programme development
High quality candidate medicines ready for clinical development:
- Robust target product profile
- Execution of clear, structured holistic drug development plan
- Delivery of compelling pre-clinical PoC data package
- Flexible models of partnership to progress through clinic and commercial launch